BTIG Affirms Merrimack Pharma (MACK) at 'Neutral' Amid Restructuring Plans
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/16/2024
- S&P, Nasdaq muted as bond yields rise; UnitedHealth boosts Dow
- UnitedHealth (UNH) beats earnings, revenue estimates in Q1; shares up
- BofA profit hurt by provisions even as it expects rising interest income
- Morgan Stanley (MS) earnings beat lifts stock
- Johnson & Johnson (JNJ) posts mixed results, narrows full-year guidance
- Trump Media & Technology Group (DJT) Files S-1
- Tesla (TSLA) Senior VP Drew Baglino Is Said To Leave The Company - Bloomberg
- General Motors (GM) Said to be Moving Detroit HQ to Dan Gilbert's Hudson Tower - Bloomberg
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- Biohaven Pharma (BHVN) presents update on degrader platform and summary of progress to date in Phase 1 single ascending dose study for BHV-1300
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
- Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
- Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall
Merrimack Pharma (MACK) will resume trading at 7:45am ET
October 3, 2016 7:28 AM EDTMerrimack Pharma (NASDAQ: MACK) will resume trading at 7:45am EDT.
... MoreMerrimack Pharma (MACK) to Undertake Major Corporate Restructuring; Will Cut Workforce by ~22%
October 3, 2016 7:16 AM EDTMerrimack Pharmaceuticals, Inc. (Nasdaq: MACK) announced a major corporate restructuring with the objective of prioritizing its research and development on a focused set of systems biology-derived oncology products and strengthening its financial runway. As part of this move, Merrimack is immediately implementing a 22% reduction in headcount and eliminating more than $200 million in expected costs over the next two years. In line with this restructuring, the Board of Directors has accepted the resignation of President and CEO Robert Mulroy, effective immediately.
In order to accelerate this change, the Board of Directors has... More
Merrimack Pharma (MACK) trading halted with news pending
October 3, 2016 7:10 AM EDTMerrimack Pharma (NASDAQ: MACK) trading halted with news pending.
... More
